Background

The human brain is completed as tens of billions of neurons form an intricate neural network. Previously, the academic community believed that most neurons generated during the normal brain development process would maintain intact genomes. This was due to the difficulty of accurately capturing minute genetic variations or somatic mutations at the individual cell level. Existing bulk tissue analysis methods grind up tens of thousands or more cells at once, facing technical limitations in distinguishing genomic abnormalities localized to specific neurons from normal cell signals.

With recent advancements in single-cell analysis technology, somatic mosaicism—where DNA sequences differ in each neuron within brain tissue—has begun to be observed. It has also been increasingly identified that chromosomal abnormalities or copy number variations are involved in the onset of neurodevelopmental disorders such as autism spectrum disorder, epilepsy, and schizophrenia. However, it remained a long-standing mystery when and how extensively these genomic abnormalities occur during the normal developmental trajectory, and how an individual maintains normal brain function.

Key Findings

Researchers applied single-neuron DNA sequencing to track the genomic stability of human cortical neurons from the fetal period to around birth. The analysis revealed widespread genomic abnormalities in a significant number of neurons comprising fetal brain tissue during the second trimester. Genetic defects, including aneuploidy, large-scale chromosomal deletions, and duplications, were widespread in fetal neurons before birth. The study revealed that during periods of explosive neuronal proliferation, abnormal cells are commonly generated due to genomic replication stress and cell division errors.

A surprising twist was captured around the time of birth. The neurons with abnormal genomes that enveloped the fetal brain rapidly disappeared just before and at birth. In mature neonatal and post-natal brain tissue, the proportion of neurons with genomic defects was observed to be extremely low. The researchers revealed that an intrinsic developmental genome quality control mechanism exists within the human brain development program to detect and filter out damaged genomes. This is interpreted as the result of activated apoptotic mechanisms or proliferation inhibition control systems that selectively weed out defective cells.

Significance and Outlook

This discovery fundamentally redefines the traditional view of human neural development. It proves that the fetal brain is not a structure that accumulates cells in an impeccable state, but rather an adaptive system that generates large quantities of defective cells and then completes itself through rigorous postnatal quality control. If the molecular operating principles of the quality control system for generators are elucidated, it could provide direct clues to identifying the causes of congenital brain diseases of unknown etiology.

It also provides a new perspective on understanding the pathophysiology of neurodevelopmental disorders. It is suggested that in a significant number of patients with pediatric epilepsy or developmental delays, abnormal cells that evaded quality control mechanisms and survived may persist in brain tissue, potentially causing the disease. However, due to limitations in obtaining human fetal brain tissue samples, it is difficult to fully reconstruct the time-course trajectory to determine exactly at which week the quality control mechanism peaks. Further verification work to identify the key molecular sensors that recognize and remove defective cells remains a follow-up task.